{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:43:15Z","timestamp":1791877395651,"version":"4.3.4"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-024-03045-8","type":"journal-article","created":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T04:58:52Z","timestamp":1735448332000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Nanoparticle and microparticle-based systems for enhanced oral insulin delivery: A systematic review and meta-analysis"],"prefix":"10.1186","volume":"22","author":[{"given":"Carlos E.","family":"Romero-Carmona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan I.","family":"Ch\u00e1vez-Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Quintanar-Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Bernad-Bernad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Ramos-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila I.","family":"Pe\u00f1a-Corona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Sharifi-Rad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Leyva-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,29]]},"reference":[{"key":"3045_CR1","unstructured":"Disease, N.I.o.D.a.D.a.K. What is diabetes? 2023 [cited 2023 October 20]; Available from: https:\/\/www.niddk.nih.gov\/health-information\/diabetes\/overview\/what-is-diabetes."},{"key":"3045_CR2","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1007\/s13346-024-01569-y","volume":"14","author":"S Zhang","year":"2024","unstructured":"Zhang S, Staples AE. Microfluidic-based systems for the management of diabetes. Drug Deliv Transl Res. 2024;14:2989.","journal-title":"Drug Deliv Transl Res"},{"key":"3045_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"Saeedi P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9. Diabetes Res Clin Pract. 2019;157: 107843.","journal-title":"Diabetes Res Clin Pract"},{"key":"3045_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108086","volume":"162","author":"P Saeedi","year":"2020","unstructured":"Saeedi P, et al. Mortality attributable to diabetes in 20\u201379 years old adults, 2019 estimates: results from the International Diabetes Federation Diabetes Atlas, 9. Diabetes Res Clin Pract. 2020;162: 108086.","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"3045_CR5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.34172\/hpp.2020.18","volume":"10","author":"M Mobasseri","year":"2020","unstructured":"Mobasseri M, et al. Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis. Health Promot Perspect. 2020;10(2):98\u2013115.","journal-title":"Health Promot Perspect"},{"issue":"10397","key":"3045_CR6","first-page":"31","volume":"402","author":"GD Collaborators","year":"2023","unstructured":"Collaborators GD. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: asystematic analysis for the Global Burden of Disease Study 2021. The Lancet. 2023;402(10397):31.","journal-title":"The Lancet"},{"issue":"9","key":"3045_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/adbi.202300172","volume":"7","author":"N Di Pietrantonio","year":"2023","unstructured":"Di Pietrantonio N, et al. Role of epigenetics and metabolomics in predicting endothelial dysfunction in type 2 diabetes. Adv Biol (Weinh). 2023;7(9): e2300172.","journal-title":"Adv Biol (Weinh)"},{"issue":"12","key":"3045_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2023.102908","volume":"17","author":"JTD N\u00f8rlev","year":"2023","unstructured":"N\u00f8rlev JTD, et al. Quantification of insulin adherence in adults with insulin-treated type 2 diabetes: a systematic review. Diabetes Metab Syndr. 2023;17(12): 102908.","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"3045_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s13346-023-01428-2","volume":"14","author":"SH Li","year":"2024","unstructured":"Li SH, et al. Metal-polyphenol microgels for oral delivery of puerarin to alleviate the onset of diabetes. Drug Deliv Transl Res. 2024;14(3):757\u201372.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"3045_CR10","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.dsx.2018.10.008","volume":"13","author":"SY Tan","year":"2019","unstructured":"Tan SY, et al. Type 1 and 2 diabetes mellitus: a review on current treatment approach and gene therapy as potential intervention. Diabetes Metab Syndr. 2019;13(1):364\u201372.","journal-title":"Diabetes Metab Syndr"},{"issue":"2","key":"3045_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S1471-4914(02)02279-7","volume":"8","author":"J-W Yoon","year":"2002","unstructured":"Yoon J-W, Jun H-S. Recent advances in insulin gene therapy for type 1 diabetes. Trends Mol Med. 2002;8(2):6.","journal-title":"Trends Mol Med"},{"issue":"7","key":"3045_CR12","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1002\/stem.1676","volume":"32","author":"TM Kono","year":"2014","unstructured":"Kono TM, et al. Human adipose-derived stromal\/stem cells protect against STZ-induced hyperglycemia: analysis of hASC-derived paracrine effectors. Stem Cells. 2014;32(7):1831\u201342.","journal-title":"Stem Cells"},{"issue":"11","key":"3045_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2023.102901","volume":"17","author":"EK Sher","year":"2023","unstructured":"Sher EK, et al. Novel therapeutical approaches based on neurobiological and genetic strategies for diabetic polyneuropathy\u2014a review. Diabetes Metab Syndr. 2023;17(11): 102901.","journal-title":"Diabetes Metab Syndr"},{"issue":"4","key":"3045_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102478","volume":"16","author":"IR El Maalouf","year":"2022","unstructured":"El Maalouf IR, Capoccia K, Priefer R. Non-invasive ways of administering insulin. Diabetes Metab Syndr. 2022;16(4): 102478.","journal-title":"Diabetes Metab Syndr"},{"issue":"8","key":"3045_CR15","doi-asserted-by":"publisher","first-page":"973","DOI":"10.4155\/TDE.15.47","volume":"6","author":"M Lopes","year":"2015","unstructured":"Lopes M, et al. Why most oral insulin formulations do not reach clinical trials. Ther Deliv. 2015;6(8):973\u201387.","journal-title":"Ther Deliv"},{"issue":"5","key":"3045_CR16","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.pcd.2021.06.004","volume":"15","author":"S Arora","year":"2021","unstructured":"Arora S, et al. Early detection of cutaneous complications of insulin therapy in type 1 and type 2 diabetes mellitus. Prim Care Diabetes. 2021;15(5):859\u201364.","journal-title":"Prim Care Diabetes"},{"issue":"10","key":"3045_CR17","doi-asserted-by":"publisher","first-page":"661","DOI":"10.2165\/00128071-200304100-00001","volume":"4","author":"T Richardson","year":"2003","unstructured":"Richardson T, Kerr D. Skin-related complications of insulin therapy: epidemiology and emerging management strategies. Am J Clin Dermatol. 2003;4(10):661\u20137.","journal-title":"Am J Clin Dermatol"},{"issue":"3","key":"3045_CR18","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1007\/s13346-023-01423-7","volume":"14","author":"RW Hammad","year":"2024","unstructured":"Hammad RW, et al. Cubosomal functionalized block copolymer platform for dual delivery of linagliptin and empagliflozin: recent advances in synergistic strategies for maximizing control of high-risk type II diabetes. Drug Deliv Transl Res. 2024;14(3):678\u201395.","journal-title":"Drug Deliv Transl Res"},{"issue":"1","key":"3045_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2337\/diaclin.34.1.25","volume":"34","author":"PM Trief","year":"2016","unstructured":"Trief PM, et al. Incorrect insulin administration: a problem that warrants attention. Clin Diabetes. 2016;34(1):25\u201333.","journal-title":"Clin Diabetes"},{"issue":"10138","key":"3045_CR20","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","volume":"391","author":"LA DiMeglio","year":"2018","unstructured":"DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet J. 2018;391(10138):2449\u201362.","journal-title":"Lancet J"},{"issue":"2","key":"3045_CR21","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","volume":"14","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018;14(2):88\u201398.","journal-title":"Nat Rev Endocrinol"},{"key":"3045_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/B978-0-323-98367-9.00025-1","volume-title":"Pharmacokinetics and toxicokinetic considerations","author":"V Pandey","year":"2022","unstructured":"Pandey V, et al. Chapter 18\u2014excipient toxicity and safety. In: Tekade RK, editor., et al., Pharmacokinetics and toxicokinetic considerations. New York: Academic Press; 2022. p. 487\u2013511."},{"issue":"4","key":"3045_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s40139-021-00227-z","volume":"9","author":"S Sharma","year":"2021","unstructured":"Sharma S, Parveen R, Chatterji BP. Toxicology of nanoparticles in drug delivery. Curr Pathobiol Rep. 2021;9(4):133\u201344.","journal-title":"Curr Pathobiol Rep"},{"issue":"Pt A","key":"3045_CR24","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.fct.2017.06.020","volume":"106","author":"AG Gil","year":"2017","unstructured":"Gil AG, et al. Toxicity and biodistribution of orally administered casein nanoparticles. Food Chem Toxicol. 2017;106(Pt A):477\u201386.","journal-title":"Food Chem Toxicol"},{"key":"3045_CR25","doi-asserted-by":"crossref","unstructured":"Harugade A, Sherje A, Pethe A. Chitosan: a review on properties, biological activities and recent progress in biomedical applications. React Funct Polym. 2023;1991.","DOI":"10.1016\/j.reactfunctpolym.2023.105634"},{"issue":"2","key":"3045_CR26","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3390\/ijms21020487","volume":"21","author":"W Wang","year":"2020","unstructured":"Wang W, et al. Chitosan derivatives and their application in biomedicine. Int J Mol Sci. 2020;21(2):487.","journal-title":"Int J Mol Sci"},{"key":"3045_CR27","doi-asserted-by":"publisher","first-page":"6829","DOI":"10.2147\/IJN.S174030","volume":"13","author":"J Xu","year":"2018","unstructured":"Xu J, et al. Chitosan-microcapsulated insulin alleviates mesenteric microcirculation dysfunction via modulating COX-2 and VCAM-1 expression in rats with diabetes mellitus. Int J Nanomed. 2018;13:6829\u201337.","journal-title":"Int J Nanomed"},{"issue":"17","key":"3045_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201800285","volume":"7","author":"H Tian","year":"2018","unstructured":"Tian H, et al. Uniform core\u2013shell nanoparticles with thiolated hyaluronic acid coating to enhance oral delivery of insulin. Adv Healthc Mater. 2018;7(17): e1800285.","journal-title":"Adv Healthc Mater"},{"key":"3045_CR29","doi-asserted-by":"publisher","first-page":"105179","DOI":"10.1039\/C5RA19115G","volume":"5","author":"A Agrawal","year":"2015","unstructured":"Agrawal A, et al. Folate appended chitosan nanoparticles augment the stability, bioavailability and efficacy of insulin in diabetic rats following oral administration. RSC Adv. 2015;5:105179\u201393.","journal-title":"RSC Adv"},{"issue":"Suppl 3","key":"3045_CR30","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/j.injury.2022.06.012","volume":"54","author":"C Papakostidis","year":"2023","unstructured":"Papakostidis C, Giannoudis PV. Meta-analysis. What have we learned? Injury. 2023;54(Suppl 3):S30\u20134.","journal-title":"Injury"},{"issue":"5","key":"3045_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.3312","volume":"23","author":"XM Wang","year":"2021","unstructured":"Wang XM, et al. A brief introduction of meta-analyses in clinical practice and research. J Gene Med. 2021;23(5): e3312.","journal-title":"J Gene Med"},{"key":"3045_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2023.102031","volume":"53","author":"T Peng","year":"2023","unstructured":"Peng T, et al. Rational design of oral delivery nanosystems for hypoglycemic peptides. Nano Today. 2023;53: 102031.","journal-title":"Nano Today"},{"key":"3045_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"issue":"Pt 1","key":"3045_CR34","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.envint.2018.07.015","volume":"121","author":"RL Morgan","year":"2018","unstructured":"Morgan RL, et al. Identifying the PECO: a framework for formulating good questions to explore the association of environmental and other exposures with health outcomes. Environ Int. 2018;121(Pt 1):1027\u201331.","journal-title":"Environ Int"},{"issue":"4","key":"3045_CR35","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. J Clin Epidemiol. 2011;64(4):395\u2013400.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"3045_CR36","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, et al. Rayyan-a web and mobile app for systematic reviews. Syst Rev. 2016;5(1):210.","journal-title":"Syst Rev"},{"key":"3045_CR37","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/B978-0-323-47347-7.00028-8","volume-title":"Nanoarchitectonics for smart delivery and drug targeting","author":"C Tiloke","year":"2016","unstructured":"Tiloke C, Phulukdaree A, Chuturgoon AA. The chemotherapeutic potential of gold nanoparticles against human carcinomas: a review. In: Andrew W, editor. Nanoarchitectonics for smart delivery and drug targeting. New York: Elsevier; 2016. p. 783\u2013811."},{"key":"3045_CR38","first-page":"415","volume-title":"Studies in natural products chemistry","author":"H Badwaik","year":"2019","unstructured":"Badwaik H, et al. Phytoconstituent plumbagin: chemical, biotechnological and pharmaceutical aspects. In: Studies in natural products chemistry. New York: Elsevier; 2019. p. 415\u201360."},{"key":"3045_CR39","unstructured":"ImageJ. [cited 01\/07\/2024; Available from: https:\/\/imagej.net\/ij\/."},{"key":"3045_CR40","unstructured":"The jamovi project. jamovi (Version 2.3) [Computer Software]. Available from: https:\/\/www.jamovi.org."},{"key":"3045_CR41","unstructured":"Cochrane.org. Chapter 10: Analysing data and undertaking meta-analyses. 2024; Available from: https:\/\/training.cochrane.org\/handbook\/current\/chapter-10."},{"issue":"44","key":"3045_CR42","first-page":"776","volume":"107","author":"A Schneider","year":"2010","unstructured":"Schneider A, Hommel G, Blettner M. Linear regression analysis: part 14 of a series on evaluation of scientific publications. Dtsch Arztebl Int. 2010;107(44):776\u201382.","journal-title":"Dtsch Arztebl Int"},{"key":"3045_CR43","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/bs.host.2020.01.002","volume-title":"Principles and methods for data science","author":"K Yeturu","year":"2020","unstructured":"Yeturu K, Srinivasa Rao ASR, Rao CR. Chapter 3\u2014Machine learning algorithms, applications, and practices in data science. In: Principles and methods for data science. New York: Elsevier; 2020. p. 81\u2013206."},{"key":"3045_CR44","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1471-2288-14-43","volume":"14","author":"CR Hooijmans","year":"2014","unstructured":"Hooijmans CR, et al. SYRCLE\u2019s risk of bias tool for animal studies. BMC Med Res Methodol. 2014;14:43.","journal-title":"BMC Med Res Methodol"},{"issue":"8","key":"3045_CR45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s10856-020-06417-2","volume":"31","author":"V Raguraman","year":"2020","unstructured":"Raguraman V, Jayasri MA, Suthindhiran K. Magnetosome mediated oral Insulin delivery and its possible use in diabetes management. J Mater Sci Mater Med. 2020;31(8):75.","journal-title":"J Mater Sci Mater Med"},{"issue":"9","key":"3045_CR46","doi-asserted-by":"publisher","first-page":"4452","DOI":"10.7150\/thno.54176","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, et al. Charge-switchable zwitterionic polycarboxybetaine particle as an intestinal permeation enhancer for efficient oral insulin delivery. Theranostics. 2021;11(9):4452\u201366.","journal-title":"Theranostics"},{"issue":"Pt 1","key":"3045_CR47","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.msec.2016.08.083","volume":"70","author":"L Li","year":"2017","unstructured":"Li L, et al. Preparation of chitosan-based multifunctional nanocarriers overcoming multiple barriers for oral delivery of insulin. Mater Sci Eng C Mater Biol Appl. 2017;70(Pt 1):278\u201386.","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"issue":"28","key":"3045_CR48","doi-asserted-by":"publisher","first-page":"15430","DOI":"10.1021\/acsami.5b03555","volume":"7","author":"J Sheng","year":"2015","unstructured":"Sheng J, et al. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption. ACS Appl Mater Interfaces. 2015;7(28):15430\u201341.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3045_CR49","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1039\/C6PY00131A","volume":"7","author":"H Guo","year":"2016","unstructured":"Guo H, et al. Phenylboronic acid-based amphiphilic glycopolymeric nanocarriers for in vivo insulin delivery. Polym Chem. 2016;7:3189\u201399.","journal-title":"Polym Chem"},{"key":"3045_CR50","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jconrel.2016.05.015","volume":"233","author":"J Sheng","year":"2016","unstructured":"Sheng J, et al. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates. J Control Release. 2016;233:181\u201390.","journal-title":"J Control Release"},{"issue":"1","key":"3045_CR51","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3390\/ijms18010054","volume":"18","author":"S Sun","year":"2016","unstructured":"Sun S, et al. Multifunctional composite microcapsules for oral delivery of insulin. Int J Mol Sci. 2016;18(1):54.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"3045_CR52","doi-asserted-by":"publisher","first-page":"4756","DOI":"10.1021\/acs.molpharmaceut.8b00708","volume":"15","author":"KS Kim","year":"2018","unstructured":"Kim KS, et al. Immense insulin intestinal uptake and lymphatic transport using bile acid conjugated partially uncapped liposome. Mol Pharm. 2018;15(10):4756\u201363.","journal-title":"Mol Pharm"},{"key":"3045_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119736","volume":"588","author":"JU Kim","year":"2020","unstructured":"Kim JU, et al. Optimization of phytic acid-crosslinked chitosan microspheres for oral insulin delivery using response surface methodology. Int J Pharm. 2020;588: 119736.","journal-title":"Int J Pharm"},{"key":"3045_CR54","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jconrel.2016.02.031","volume":"227","author":"M Alibolandi","year":"2016","unstructured":"Alibolandi M, et al. Dextran-b-poly(lactide-co-glycolide) polymersome for oral delivery of insulin: in vitro and in vivo evaluation. J Control Release. 2016;227:58\u201370.","journal-title":"J Control Release"},{"issue":"3","key":"3045_CR55","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1080\/10837450.2016.1213745","volume":"22","author":"M Al-Remawi","year":"2017","unstructured":"Al-Remawi M, et al. Chitosan\/lecithin liposomal nanovesicles as an oral insulin delivery system. Pharm Dev Technol. 2017;22(3):390\u20138.","journal-title":"Pharm Dev Technol"},{"issue":"5","key":"3045_CR56","doi-asserted-by":"publisher","first-page":"675","DOI":"10.3390\/biom10050675","volume":"10","author":"M Amaral","year":"2020","unstructured":"Amaral M, et al. How can biomolecules improve mucoadhesion of oral insulin? A comprehensive insight using. Biomolecules. 2020;10(5):675.","journal-title":"Biomolecules"},{"issue":"13","key":"3045_CR57","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1039\/C9TB02860A","volume":"8","author":"Y Bai","year":"2020","unstructured":"Bai Y, et al. Nanoparticles with surface features of dendritic oligopeptides as potential oral drug delivery systems. J Mater Chem B. 2020;8(13):2636\u201349.","journal-title":"J Mater Chem B"},{"key":"3045_CR58","doi-asserted-by":"crossref","unstructured":"Balabushevich NG, et al. Layer-by-layer adsorption of biopolyelectrolytes as a universal approach to fabrication of protein-loaded microparticles. Moscow University Chemistry Bulletin. 2014.","DOI":"10.3103\/S002713141403002X"},{"issue":"1","key":"3045_CR59","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/02652048.2019.1604846","volume":"36","author":"T Chen","year":"2019","unstructured":"Chen T, et al. Self-assembly pH-sensitive chitosan\/alginate coated polyelectrolyte complexes for oral delivery of insulin. J Microencapsul. 2019;36(1):96\u2013107.","journal-title":"J Microencapsul"},{"key":"3045_CR60","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ijpharm.2019.03.020","volume":"562","author":"X Chen","year":"2019","unstructured":"Chen X, et al. Cp1-11 peptide\/insulin complex loaded pH-responsive nanoparticles with enhanced oral bioactivity. Int J Pharm. 2019;562:23\u201330.","journal-title":"Int J Pharm"},{"key":"3045_CR61","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijbiomac.2013.10.026","volume":"63","author":"HJ Cho","year":"2014","unstructured":"Cho HJ, et al. Chondroitin sulfate-capped gold nanoparticles for the oral delivery of insulin. Int J Biol Macromol. 2014;63:15\u201320.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"3045_CR62","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/md16010032","volume":"16","author":"AM Elsayed","year":"2018","unstructured":"Elsayed AM, et al. Low molecular weight chitosan\u2013insulin complexes solubilized in a mixture of self-assembled labrosol and plurol oleaque and their glucose reduction activity in rats. Mar Drugs. 2018;16(1):32.","journal-title":"Mar Drugs"},{"key":"3045_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2019.118708","volume":"571","author":"ES El Leithy","year":"2019","unstructured":"El Leithy ES, Abdel-Bar HM, Ali RA. Folate-chitosan nanoparticles triggered insulin cellular uptake and improved in vivo hypoglycemic activity. Int J Pharm. 2019;571: 118708.","journal-title":"Int J Pharm"},{"issue":"9","key":"3045_CR64","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.xphs.2019.04.020","volume":"108","author":"Y Fang","year":"2019","unstructured":"Fang Y, et al. Gastrointestinal responsive polymeric nanoparticles for oral delivery of insulin: optimized preparation, characterization, and in vivo evaluation. J Pharm Sci. 2019;108(9):2994\u20133002.","journal-title":"J Pharm Sci"},{"issue":"Pt A","key":"3045_CR65","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jcis.2020.08.010","volume":"582","author":"Y Gao","year":"2021","unstructured":"Gao Y, et al. Zwitterion-functionalized mesoporous silica nanoparticles for enhancing oral delivery of protein drugs by overcoming multiple gastrointestinal barriers. J Colloid Interface Sci. 2021;582(Pt A):364\u201375.","journal-title":"J Colloid Interface Sci"},{"issue":"1\u20132","key":"3045_CR66","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ijpharm.2015.08.004","volume":"493","author":"H He","year":"2015","unstructured":"He H, et al. VB12-coated Gel-Core-SLN containing insulin: another way to improve oral absorption. Int J Pharm. 2015;493(1\u20132):451\u20139.","journal-title":"Int J Pharm"},{"issue":"7","key":"3045_CR67","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1039\/C7NR08047F","volume":"10","author":"Z He","year":"2018","unstructured":"He Z, et al. Scalable production of core\u2013shell nanoparticles by flash nanocomplexation to enhance mucosal transport for oral delivery of insulin. Nanoscale. 2018;10(7):3307\u201319.","journal-title":"Nanoscale"},{"issue":"13","key":"3045_CR68","doi-asserted-by":"publisher","first-page":"7887","DOI":"10.1039\/D0RA00382D","volume":"10","author":"Y Hu","year":"2020","unstructured":"Hu Y, Wang J, Qiu L. Polymeric nano-vesicles via intermolecular action to load and orally deliver insulin with enhanced hypoglycemic effect. RSC Adv. 2020;10(13):7887\u201397.","journal-title":"RSC Adv"},{"issue":"6","key":"3045_CR69","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s13346-020-00796-3","volume":"10","author":"L Inchaurraga","year":"2020","unstructured":"Inchaurraga L, et al. Zein-based nanoparticles for the oral delivery of insulin. Drug Deliv Transl Res. 2020;10(6):1601\u201311.","journal-title":"Drug Deliv Transl Res"},{"key":"3045_CR70","doi-asserted-by":"publisher","first-page":"58137","DOI":"10.1039\/C4RA09771H","volume":"4","author":"Y Jin","year":"2014","unstructured":"Jin Y, et al. Chitosan modified cerasomes incorporating poly (vinyl pyrrolidone) for oral insulin delivery. RSC Adv. 2014;4:58137\u201344.","journal-title":"RSC Adv"},{"key":"3045_CR71","first-page":"3664","volume":"9","author":"M Kassem","year":"2018","unstructured":"Kassem M, et al. Formulation, characterization and in vivo application of oral insulin nanotechnology using different biodegradable polymers: advanced drug delivery system. Int J Pharm Sci Res. 2018;9:3664\u201377.","journal-title":"Int J Pharm Sci Res"},{"key":"3045_CR72","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.ijbiomac.2020.01.302","volume":"149","author":"Y Kumari","year":"2020","unstructured":"Kumari Y, et al. Modified apple polysaccharide capped gold nanoparticles for oral delivery of insulin. Int J Biol Macromol. 2020;149:976\u201388.","journal-title":"Int J Biol Macromol"},{"key":"3045_CR73","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.biomaterials.2016.06.059","volume":"103","author":"JH Lee","year":"2016","unstructured":"Lee JH, et al. ZOT-derived peptide and chitosan functionalized nanocarrier for oral delivery of protein drug. Biomaterials. 2016;103:160\u20139.","journal-title":"Biomaterials"},{"issue":"1","key":"3045_CR74","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12951-020-00662-x","volume":"18","author":"SH Lee","year":"2020","unstructured":"Lee SH, et al. Enhanced oral delivery of insulin via the colon-targeted nanocomposite system of organoclay\/glycol chitosan\/Eudragit. J Nanobiotechnol. 2020;18(1):104.","journal-title":"J Nanobiotechnol"},{"issue":"37","key":"3045_CR75","doi-asserted-by":"publisher","first-page":"9678","DOI":"10.1016\/j.biomaterials.2013.08.048","volume":"34","author":"X Li","year":"2013","unstructured":"Li X, et al. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles. Biomaterials. 2013;34(37):9678\u201387.","journal-title":"Biomaterials"},{"issue":"3","key":"3045_CR76","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.apsb.2021.07.024","volume":"12","author":"J Li","year":"2022","unstructured":"Li J, et al. The upregulated intestinal folate transporters direct the uptake of ligand-modified nanoparticles for enhanced oral insulin delivery. Acta Pharm Sin B. 2022;12(3):1460\u201372.","journal-title":"Acta Pharm Sin B"},{"key":"3045_CR77","doi-asserted-by":"publisher","first-page":"761","DOI":"10.2147\/IJN.S96146","volume":"11","author":"L Liu","year":"2016","unstructured":"Liu L, et al. Self-assembled lecithin\/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation. Int J Nanomed. 2016;11:761\u20139.","journal-title":"Int J Nanomed"},{"issue":"6","key":"3045_CR78","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.3109\/10717544.2015.1058433","volume":"23","author":"C Liu","year":"2016","unstructured":"Liu C, et al. A novel ligand conjugated nanoparticles for oral insulin delivery. Drug Deliv. 2016;23(6):2015\u201325.","journal-title":"Drug Deliv"},{"key":"3045_CR79","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jconrel.2015.12.008","volume":"222","author":"M Liu","year":"2016","unstructured":"Liu M, et al. Efficient mucus permeation and tight junction opening by dissociable \u201cmucus-inert\u201d agent coated trimethyl chitosan nanoparticles for oral insulin delivery. J Control Release. 2016;222:67\u201377.","journal-title":"J Control Release"},{"issue":"8","key":"3045_CR80","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1021\/acsbiomaterials.8b00646","volume":"4","author":"L Liu","year":"2018","unstructured":"Liu L, et al. Dual stimuli-responsive nanoparticle-incorporated hydrogels as an oral insulin carrier for intestine-targeted delivery and enhanced paracellular permeation. ACS Biomater Sci Eng. 2018;4(8):2889\u2013902.","journal-title":"ACS Biomater Sci Eng"},{"issue":"4","key":"3045_CR81","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1039\/C7TB02450A","volume":"6","author":"M Liu","year":"2018","unstructured":"Liu M, et al. Iron-mimic peptide converts transferrin from foe to friend for orally targeting insulin delivery. J Mater Chem B. 2018;6(4):593\u2013601.","journal-title":"J Mater Chem B"},{"issue":"8","key":"3045_CR82","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1039\/D1BM00020A","volume":"9","author":"X Liu","year":"2021","unstructured":"Liu X, et al. Angiopep-2-functionalized nanoparticles enhance transport of protein drugs across intestinal epithelia by self-regulation of targeted receptors. Biomater Sci. 2021;9(8):2903\u201316.","journal-title":"Biomater Sci"},{"key":"3045_CR83","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ejpb.2016.11.037","volume":"113","author":"M Lopes","year":"2017","unstructured":"Lopes M, et al. In vivo biodistribution of antihyperglycemic biopolymer-based nanoparticles for the treatment of type 1 and type 2 diabetes. Eur J Pharm Biopharm. 2017;113:88\u201396.","journal-title":"Eur J Pharm Biopharm"},{"issue":"9","key":"3045_CR84","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.3390\/ph15091062","volume":"15","author":"AL Mart\u00ednez-L\u00f3pez","year":"2022","unstructured":"Mart\u00ednez-L\u00f3pez AL, et al. Arabinoxylans-based oral insulin delivery system targeting the colon: simulation in a human intestinal microbial ecosystem and evaluation in diabetic rats. Pharmaceuticals (Basel). 2022;15(9):1062.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3045_CR85","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.2147\/IJN.S199507","volume":"14","author":"J Mudassir","year":"2019","unstructured":"Mudassir J, et al. Self-assembled insulin and nanogels polyelectrolyte complex (Ins\/NGs-PEC) for oral insulin delivery: characterization, lyophilization and in-vivo evaluation. Int J Nanomed. 2019;14:4895\u2013909.","journal-title":"Int J Nanomed"},{"issue":"2","key":"3045_CR86","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1080\/10837450.2020.1849282","volume":"26","author":"NB Mutlu-Agardan","year":"2021","unstructured":"Mutlu-Agardan NB, Han S. In vitro and in vivo evaluations on nanoparticle and phospholipid hybrid nanoparticles with absorption enhancers for oral insulin delivery. Pharm Dev Technol. 2021;26(2):157\u201366.","journal-title":"Pharm Dev Technol"},{"issue":"2","key":"3045_CR87","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1515\/acph-2017-0020","volume":"67","author":"PK Paul","year":"2017","unstructured":"Paul PK, Treetong A, Suedee R. Biomimetic insulin-imprinted polymer nanoparticles as a potential oral drug delivery system. Acta Pharm. 2017;67(2):149\u201368.","journal-title":"Acta Pharm"},{"issue":"3","key":"3045_CR88","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1039\/D0BM01772H","volume":"9","author":"R Rao","year":"2021","unstructured":"Rao R, et al. Bioinspired zwitterionic polyphosphoester modified porous silicon nanoparticles for efficient oral insulin delivery. Biomater Sci. 2021;9(3):685\u201399.","journal-title":"Biomater Sci"},{"issue":"1","key":"3045_CR89","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/pharmaceutics14010039","volume":"14","author":"C Reboredo","year":"2021","unstructured":"Reboredo C, et al. Zein-based nanoparticles as oral carriers for insulin delivery. Pharmaceutics. 2021;14(1):39.","journal-title":"Pharmaceutics"},{"key":"3045_CR90","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1166\/jbn.2015.1904","volume":"11","author":"MR Rekha","year":"2015","unstructured":"Rekha MR, Sharma C. Simultaneous effect of thiolation and carboxylation of chitosan particles towards mucoadhesive oral insulin delivery applications: an in vitro and in vivo evaluation. J Biomed Nanotechnol. 2015;11:11.","journal-title":"J Biomed Nanotechnol"},{"issue":"3","key":"3045_CR91","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1021\/acsnano.5b00028","volume":"9","author":"W Shan","year":"2015","unstructured":"Shan W, et al. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin. ACS Nano. 2015;9(3):2345\u201356.","journal-title":"ACS Nano"},{"issue":"38","key":"3045_CR92","doi-asserted-by":"publisher","first-page":"25444","DOI":"10.1021\/acsami.6b08183","volume":"8","author":"W Shan","year":"2016","unstructured":"Shan W, et al. Enhanced oral delivery of protein drugs using zwitterion-functionalized nanoparticles to overcome both the diffusion and absorption barriers. ACS Appl Mater Interfaces. 2016;8(38):25444\u201353.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"16","key":"3045_CR93","doi-asserted-by":"publisher","first-page":"4138","DOI":"10.1021\/acs.jafc.5b00393","volume":"63","author":"W Situ","year":"2015","unstructured":"Situ W, et al. Preparation and characterization of glycoprotein-resistant starch complex as a coating material for oral bioadhesive microparticles for colon-targeted polypeptide delivery. J Agric Food Chem. 2015;63(16):4138\u201347.","journal-title":"J Agric Food Chem"},{"issue":"4","key":"3045_CR94","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1166\/jbn.2014.1740","volume":"10","author":"TA Sonia","year":"2014","unstructured":"Sonia TA, Sharma CP. pH sensitive thiolated cationic hydrogel for oral insulin delivery. J Biomed Nanotechnol. 2014;10(4):642\u201350.","journal-title":"J Biomed Nanotechnol"},{"key":"3045_CR95","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ijbiomac.2020.02.079","volume":"150","author":"S Sudhakar","year":"2020","unstructured":"Sudhakar S, et al. Biodistribution and pharmacokinetics of thiolated chitosan nanoparticles for oral delivery of insulin in vivo. Int J Biol Macromol. 2020;150:281\u20138.","journal-title":"Int J Biol Macromol"},{"key":"3045_CR96","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1039\/C3PY01416A","volume":"5","author":"L Sun","year":"2014","unstructured":"Sun L, et al. Oral glucose- and pH-sensitive nanocarriers for simulating insulin release in vivo. Polym Chem. 2014;5:1999\u20132009.","journal-title":"Polym Chem"},{"issue":"1","key":"3045_CR97","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/acs.biomac.8b01530","volume":"20","author":"L Sun","year":"2019","unstructured":"Sun L, et al. Scalable manufacturing of enteric encapsulation systems for site-specific oral insulin delivery. Biomacromol. 2019;20(1):528\u201338.","journal-title":"Biomacromol"},{"issue":"9","key":"3045_CR98","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1021\/acs.molpharmaceut.0c00223","volume":"17","author":"X Tan","year":"2020","unstructured":"Tan X, et al. Hydrophilic and electroneutral nanoparticles to overcome mucus trapping and enhance oral delivery of insulin. Mol Pharm. 2020;17(9):3177\u201391.","journal-title":"Mol Pharm"},{"issue":"3","key":"3045_CR99","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1208\/s12249-019-1330-2","volume":"20","author":"D Urimi","year":"2019","unstructured":"Urimi D, et al. Polyglutamic acid functionalization of chitosan nanoparticles enhances the therapeutic efficacy of insulin following oral administration. AAPS PharmSciTech. 2019;20(3):131.","journal-title":"AAPS PharmSciTech"},{"key":"3045_CR100","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.actbio.2015.12.017","volume":"31","author":"A Verma","year":"2016","unstructured":"Verma A, et al. Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: a mucoadhesive and pH responsive carrier for improved oral delivery of insulin. Acta Biomater. 2016;31:288\u2013300.","journal-title":"Acta Biomater"},{"issue":"3","key":"3045_CR101","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/pharmaceutics15030820","volume":"15","author":"S Wang","year":"2023","unstructured":"Wang S, et al. pH-responsive and mucoadhesive nanoparticles for enhanced oral insulin delivery: the effect of hyaluronic acid with different molecular weights. Pharmaceutics. 2023;15(3):820.","journal-title":"Pharmaceutics"},{"issue":"6","key":"3045_CR102","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/j.xphs.2019.01.027","volume":"108","author":"S Wu","year":"2019","unstructured":"Wu S, et al. A delivery system for oral administration of proteins\/peptides through bile acid transport channels. J Pharm Sci. 2019;108(6):2143\u201352.","journal-title":"J Pharm Sci"},{"issue":"6","key":"3045_CR103","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1039\/D0TB02848G","volume":"9","author":"L Xing","year":"2021","unstructured":"Xing L, et al. Complying with the physiological functions of Golgi apparatus for secretory exocytosis facilitated oral absorption of protein drugs. J Mater Chem B. 2021;9(6):1707\u201318.","journal-title":"J Mater Chem B"},{"issue":"11","key":"3045_CR104","doi-asserted-by":"publisher","first-page":"9315","DOI":"10.1021\/acsami.8b00507","volume":"10","author":"Y Xu","year":"2018","unstructured":"Xu Y, et al. Novel solid lipid nanoparticle with endosomal escape function for oral delivery of insulin. ACS Appl Mater Interfaces. 2018;10(11):9315\u201324.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"4","key":"3045_CR105","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1166\/jbn.2013.1572","volume":"9","author":"ZH Zhang","year":"2013","unstructured":"Zhang ZH, et al. N-octyl-N-Arginine chitosan micelles as an oral delivery system of insulin. J Biomed Nanotechnol. 2013;9(4):601\u20139.","journal-title":"J Biomed Nanotechnol"},{"issue":"2","key":"3045_CR106","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ijpharm.2015.10.078","volume":"496","author":"P Zhang","year":"2015","unstructured":"Zhang P, et al. Goblet cell targeting nanoparticle containing drug-loaded micelle cores for oral delivery of insulin. Int J Pharm. 2015;496(2):993\u20131005.","journal-title":"Int J Pharm"},{"issue":"45","key":"3045_CR107","doi-asserted-by":"publisher","first-page":"7451","DOI":"10.1039\/C8TB02113A","volume":"6","author":"L Zhang","year":"2018","unstructured":"Zhang L, et al. Preparation and characterization of layer-by-layer hypoglycemic nanoparticles with pH-sensitivity for oral insulin delivery. J Mater Chem B. 2018;6(45):7451\u201361.","journal-title":"J Mater Chem B"},{"issue":"40","key":"3045_CR108","doi-asserted-by":"publisher","first-page":"34039","DOI":"10.1021\/acsami.8b13707","volume":"10","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, et al. Multifunctional nanoparticles enable efficient oral delivery of biomacromolecules via improving payload stability and regulating the transcytosis pathway. ACS Appl Mater Interfaces. 2018;10(40):34039\u201349.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"20","key":"3045_CR109","doi-asserted-by":"publisher","first-page":"22581","DOI":"10.1021\/acsami.0c04303","volume":"12","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, et al. A nanocomposite vehicle based on metal\u2013organic framework nanoparticle incorporated biodegradable microspheres for enhanced oral insulin delivery. ACS Appl Mater Interfaces. 2020;12(20):22581\u201392.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"1","key":"3045_CR110","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1021\/acs.molpharmaceut.9b00971","volume":"17","author":"S Zhou","year":"2020","unstructured":"Zhou S, et al. Thiolated nanoparticles overcome the mucus barrier and epithelial barrier for oral delivery of insulin. Mol Pharm. 2020;17(1):239\u201350.","journal-title":"Mol Pharm"},{"issue":"1","key":"3045_CR111","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12951-020-00652-z","volume":"18","author":"X Zhou","year":"2020","unstructured":"Zhou X, et al. Oral delivery of insulin with intelligent glucose-responsive switch for blood glucose regulation. J Nanobiotechnol. 2020;18(1):96.","journal-title":"J Nanobiotechnol"},{"issue":"10","key":"3045_CR112","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.2217\/nnm.15.36","volume":"10","author":"K Chaturvedi","year":"2015","unstructured":"Chaturvedi K, et al. Oral insulin delivery using deoxycholic acid conjugated PEGylated polyhydroxybutyrate co-polymeric nanoparticles. Nanomedicine (Lond). 2015;10(10):1569\u201383.","journal-title":"Nanomedicine (Lond)"},{"issue":"3","key":"3045_CR113","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1039\/C7NR06063G","volume":"10","author":"Y Cui","year":"2018","unstructured":"Cui Y, et al. The combination of endolysosomal escape and basolateral stimulation to overcome the difficulties of \u201ceasy uptake hard transcytosis\u201d of ligand-modified nanoparticles in oral drug delivery. Nanoscale. 2018;10(3):1494\u2013507.","journal-title":"Nanoscale"},{"key":"3045_CR114","doi-asserted-by":"publisher","first-page":"3055","DOI":"10.2147\/IJN.S198108","volume":"14","author":"XB Hu","year":"2019","unstructured":"Hu XB, et al. Phospholipid complex based nanoemulsion system for oral insulin delivery: preparation, in vitro, and in vivo evaluations. Int J Nanomed. 2019;14:3055\u201367.","journal-title":"Int J Nanomed"},{"key":"3045_CR115","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.jconrel.2017.07.045","volume":"262","author":"L Wu","year":"2017","unstructured":"Wu L, et al. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs. J Control Release. 2017;262:273\u201383.","journal-title":"J Control Release"},{"issue":"12","key":"3045_CR116","doi-asserted-by":"publisher","first-page":"9916","DOI":"10.1021\/acsami.7b16524","volume":"10","author":"J Wu","year":"2018","unstructured":"Wu J, et al. Biomimetic viruslike and charge reversible nanoparticles to sequentially overcome mucus and epithelial barriers for oral insulin delivery. ACS Appl Mater Interfaces. 2018;10(12):9916\u201328.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3045_CR117","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jconrel.2020.04.013","volume":"323","author":"L Wu","year":"2020","unstructured":"Wu L, et al. Promoting apical-to-basolateral unidirectional transport of nanoformulations by manipulating the nutrient-absorption pathway. J Control Release. 2020;323:151\u201360.","journal-title":"J Control Release"},{"issue":"1","key":"3045_CR118","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.ijpharm.2013.06.051","volume":"454","author":"X Zhao","year":"2013","unstructured":"Zhao X, et al. Preparation, characterization, and evaluation in vivo of Ins-SiO2-HP55 (insulin-loaded silica coating HP55) for oral delivery of insulin. Int J Pharm. 2013;454(1):278\u201384.","journal-title":"Int J Pharm"},{"issue":"6","key":"3045_CR119","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1039\/C6TB02475K","volume":"5","author":"Y Cui","year":"2017","unstructured":"Cui Y, et al. A strategy for developing effective orally-delivered nanoparticles through modulation of the surface \u201chydrophilicity\/hydrophobicity balance.\u201d J Mater Chem B. 2017;5(6):1302\u201314.","journal-title":"J Mater Chem B"},{"issue":"14","key":"3045_CR120","doi-asserted-by":"publisher","first-page":"3979","DOI":"10.1039\/D0BM00577K","volume":"8","author":"Y Ding","year":"2020","unstructured":"Ding Y, et al. Cholesterol moieties as building blocks for assembling nanoparticles to achieve effective oral delivery of insulin. Biomater Sci. 2020;8(14):3979\u201393.","journal-title":"Biomater Sci"},{"issue":"9","key":"3045_CR121","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1080\/10717544.2016.1209796","volume":"23","author":"A Guha","year":"2016","unstructured":"Guha A, et al. pH responsive cylindrical MSN for oral delivery of insulin-design, fabrication and evaluation. Drug Deliv. 2016;23(9):3552\u201361.","journal-title":"Drug Deliv"},{"issue":"1","key":"3045_CR122","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12951-022-01260-9","volume":"20","author":"X Jia","year":"2022","unstructured":"Jia X, et al. Multi-functional self-assembly nanoparticles originating from small molecule natural product for oral insulin delivery through modulating tight junctions. J Nanobiotechnol. 2022;20(1):116.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"3045_CR123","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1021\/acs.biomac.8b00215","volume":"19","author":"L Liu","year":"2018","unstructured":"Liu L, et al. pH- and amylase-responsive carboxymethyl starch\/poly(2-isobutyl-acrylic acid) hybrid microgels as effective enteric carriers for oral insulin delivery. Biomacromol. 2018;19(6):2123\u201336.","journal-title":"Biomacromol"},{"key":"3045_CR124","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ejpb.2021.02.014","volume":"163","author":"AM Morales-Burgos","year":"2021","unstructured":"Morales-Burgos AM, et al. Highly cross-linked arabinoxylans microspheres as a microbiota-activated carrier for colon-specific insulin delivery. Eur J Pharm Biopharm. 2021;163:16\u201322.","journal-title":"Eur J Pharm Biopharm"},{"issue":"16","key":"3045_CR125","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1021\/jf500472b","volume":"62","author":"W Situ","year":"2014","unstructured":"Situ W, et al. Resistant starch film-coated microparticles for an oral colon-specific polypeptide delivery system and its release behaviors. J Agric Food Chem. 2014;62(16):3599\u2013609.","journal-title":"J Agric Food Chem"},{"issue":"6","key":"3045_CR126","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801010","volume":"8","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, et al. Scalable production of therapeutic protein nanoparticles using flash nanoprecipitation. Adv Healthc Mater. 2019;8(6): e1801010.","journal-title":"Adv Healthc Mater"},{"issue":"5","key":"3045_CR127","first-page":"600","volume":"50","author":"PV Turner","year":"2011","unstructured":"Turner PV, et al. Administration of substances to laboratory animals: routes of administration and factors to consider. J Am Assoc Lab Anim Sci. 2011;50(5):600\u201313.","journal-title":"J Am Assoc Lab Anim Sci"},{"key":"3045_CR128","doi-asserted-by":"publisher","first-page":"113","DOI":"10.33380\/2305-2066-2020-9-2-113-118","volume":"9","author":"T Kovshova","year":"2020","unstructured":"Kovshova T, et al. Optimization of methods for determination of the encapsulation efficiency of doxorubicin in the nanoparticles based on poly(lactic-co-glycolic acid) (PLGA). Drug Dev Regis. 2020;9:113\u20138.","journal-title":"Drug Dev Regis"},{"key":"3045_CR129","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124399","volume":"661","author":"R Kamelnia","year":"2024","unstructured":"Kamelnia R, et al. Improving the stability of insulin through effective chemical modifications: a comprehensive review. Int J Pharm. 2024;661: 124399.","journal-title":"Int J Pharm"},{"issue":"1","key":"3045_CR130","doi-asserted-by":"publisher","first-page":"20230205","DOI":"10.1515\/ntrev-2023-0205","volume":"13","author":"M Alfatama","year":"2024","unstructured":"Alfatama M, et al. A comprehensive review of oral chitosan drug delivery systems: applications for oral insulin delivery. Nanotechnol Rev. 2024;13(1):20230205.","journal-title":"Nanotechnol Rev"},{"issue":"7","key":"3045_CR131","doi-asserted-by":"publisher","first-page":"945","DOI":"10.3390\/ph17070945","volume":"17","author":"A Caturano","year":"2024","unstructured":"Caturano A, et al. Advances in Nanomedicine for Precision Insulin Delivery. Pharmaceuticals (Basel). 2024;17(7):945.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"8","key":"3045_CR132","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","volume":"24","author":"DR Bhumkar","year":"2007","unstructured":"Bhumkar DR, et al. Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin. Pharm Res. 2007;24(8):1415\u201326.","journal-title":"Pharm Res"},{"issue":"11","key":"3045_CR133","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/1753-0407.13333","volume":"14","author":"Z Bloomgarden","year":"2022","unstructured":"Bloomgarden Z. Novel approaches to the treatment of type 1 diabetes. J Diabetes. 2022;14(11):724\u20136.","journal-title":"J Diabetes"},{"issue":"4","key":"3045_CR134","doi-asserted-by":"publisher","DOI":"10.1111\/jne.12941","volume":"33","author":"T Fujikawa","year":"2021","unstructured":"Fujikawa T. Central regulation of glucose metabolism in an insulin-dependent and -independent manner. J Neuroendocrinol. 2021;33(4): e12941.","journal-title":"J Neuroendocrinol"},{"issue":"6","key":"3045_CR135","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/dme.12189","volume":"30","author":"S Dube","year":"2013","unstructured":"Dube S, et al. Assessment of insulin action on carbohydrate metabolism: physiological and non-physiological methods. Diabet Med. 2013;30(6):664\u201370.","journal-title":"Diabet Med"},{"key":"3045_CR136","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbacli.2016.02.001","volume":"5","author":"MM Adeva-Andany","year":"2016","unstructured":"Adeva-Andany MM, et al. Glycogen metabolism in humans. BBA Clin. 2016;5:85\u2013100.","journal-title":"BBA Clin"},{"issue":"1","key":"3045_CR137","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3390\/ani3010238","volume":"3","author":"NH Franco","year":"2013","unstructured":"Franco NH. Animal experiments in biomedical research: a historical perspective. Animals (Basel). 2013;3(1):238\u201373.","journal-title":"Animals (Basel)"},{"key":"3045_CR138","doi-asserted-by":"crossref","unstructured":"Scridon A, et al. Wistar rats with long-term streptozotocin-induced type 1 diabetes mellitus replicate the most relevant clinical, biochemical, and hematologic features of human diabetes \/ Sobolanii Wistar cu diabet zaharat tip 1 indus cu streptozotocina reproduc cele mai relevante caracteristici clinice, biochimice si hematologice ale diabetului uman. Revista Romana de Medicina de Laborator. 2015. 23.","DOI":"10.1515\/rrlm-2015-0028"},{"issue":"10","key":"3045_CR139","doi-asserted-by":"publisher","first-page":"835","DOI":"10.4239\/wjd.v13.i10.835","volume":"13","author":"G Nagy","year":"2022","unstructured":"Nagy G, et al. New therapeutic approaches for type 1 diabetes: Disease-modifying therapies. World J Diabetes. 2022;13(10):835\u201350.","journal-title":"World J Diabetes"},{"key":"3045_CR140","doi-asserted-by":"publisher","first-page":"11057","DOI":"10.3390\/ijms231911057","volume":"23","author":"L Winkel","year":"2022","unstructured":"Winkel L, et al. Fetal programming of the endocrine pancreas: impact of a maternal low-protein diet on gene expression in the perinatal rat pancreas. Int J Mol Sci. 2022;23:11057. https:\/\/doi.org\/10.3390\/ijms231911057.","journal-title":"Int J Mol Sci"},{"key":"3045_CR141","first-page":"1431","volume":"20","author":"A Ghasemi","year":"2021","unstructured":"Ghasemi A, Jeddi S, Kashfi K. The laboratory rat: age and body weight matter. EXCLI J. 2021;20:1431\u201345.","journal-title":"EXCLI J"},{"issue":"5\u20136","key":"3045_CR142","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1242\/dmm.002733","volume":"2","author":"PM Iannaccone","year":"2009","unstructured":"Iannaccone PM, Jacob HJ. Rats! Dis Model Mech. 2009;2(5\u20136):206\u201310.","journal-title":"Dis Model Mech"},{"key":"3045_CR143","first-page":"311","volume":"3","author":"D Zhu","year":"2023","unstructured":"Zhu D. Advantages and disadvantages of different insulin administration methods for the treatment of diabetes. Adv Humanit Res. 2023;3:311\u20135.","journal-title":"Adv Humanit Res"},{"issue":"6","key":"3045_CR144","doi-asserted-by":"publisher","first-page":"3362","DOI":"10.3390\/ijms23063362","volume":"23","author":"M Wang","year":"2022","unstructured":"Wang M, et al. Versatile oral insulin delivery nanosystems: from materials to nanostructures. Int J Mol Sci. 2022;23(6):3362.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3045_CR145","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ijpharm.2012.03.056","volume":"440","author":"MR Rekha","year":"2013","unstructured":"Rekha MR, Sharma CP. Oral delivery of therapeutic protein\/peptide for diabetes\u2013future perspectives. Int J Pharm. 2013;440(1):48\u201362.","journal-title":"Int J Pharm"},{"key":"3045_CR146","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-9798-5_1","volume":"2059","author":"KK Jain","year":"2020","unstructured":"Jain KK. An overview of drug delivery systems. Methods Mol Biol. 2020;2059:1\u201354.","journal-title":"Methods Mol Biol"},{"issue":"10","key":"3045_CR147","doi-asserted-by":"publisher","first-page":"307","DOI":"10.3390\/ph13100307","volume":"13","author":"S Seyam","year":"2020","unstructured":"Seyam S, Nordin NA, Alfatama M. Recent progress of chitosan and chitosan derivatives-based nanoparticles: pharmaceutical perspectives of oral insulin delivery. Pharmaceuticals (Basel). 2020;13(10):307.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"1","key":"3045_CR148","volume":"2005","author":"B Richter","year":"2005","unstructured":"Richter B, Neises G. \u201cHuman\u201d insulin versus animal insulin in people with diabetes mellitus. Cochrane Database Syst Rev. 2005;2005(1): CD003816.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"3045_CR149","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0098856","volume":"9","author":"JA Hirst","year":"2014","unstructured":"Hirst JA, et al. The need for randomization in animal trials: an overview of systematic reviews. PLoS ONE. 2014;9(6): e98856.","journal-title":"PLoS ONE"},{"key":"3045_CR150","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1186\/s13063-015-0920-x","volume":"16","author":"BC Kahan","year":"2015","unstructured":"Kahan BC, Rehal S, Cro S. Risk of selection bias in randomised trials. Trials. 2015;16:405.","journal-title":"Trials"},{"issue":"2","key":"3045_CR151","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3390\/pharmaceutics10020057","volume":"10","author":"M Danaei","year":"2018","unstructured":"Danaei M, et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics. 2018;10(2):57.","journal-title":"Pharmaceutics"},{"key":"3045_CR152","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.101046","volume":"36","author":"K Yang","year":"2021","unstructured":"Yang K, et al. Polymers and inorganic nanoparticles: a winning combination towards assembled nanostructures for cancer imaging and therapy. Nano Toady. 2021;36: 101046.","journal-title":"Nano Toady"},{"issue":"5","key":"3045_CR153","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.1021\/acs.jpcc.9b11371","volume":"124","author":"D Biriukov","year":"2020","unstructured":"Biriukov D, Fibich P, P\u0159edota M. Zeta potential determination from molecular simulations. J Phys Chem C. 2020;124(5):3159\u201370.","journal-title":"J Phys Chem C"},{"key":"3045_CR154","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jcis.2014.05.013","volume":"429","author":"JA Eldridge","year":"2014","unstructured":"Eldridge JA, et al. Nanoparticle \u03b6-potential measurements using tunable resistive pulse sensing with variable pressure. J Colloid Interface Sci. 2014;429:45\u201352.","journal-title":"J Colloid Interface Sci"},{"key":"3045_CR155","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.jconrel.2022.12.028","volume":"353","author":"J Xu","year":"2023","unstructured":"Xu J, et al. Applications and challenges of ultra-small particle size nanoparticles in tumor therapy. J Control Release. 2023;353:699\u2013712.","journal-title":"J Control Release"},{"key":"3045_CR156","unstructured":"ACTTR. What Does \"Span\" of Particle Size Mean? 2020; Available from: https:\/\/www.acttr.com\/en\/en-faq\/en-faq-particle-size-analyzer\/411-en-faq-particle-span-meaning.html."},{"issue":"9","key":"3045_CR157","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1002\/cplu.202000496","volume":"85","author":"Y Liu","year":"2020","unstructured":"Liu Y, et al. Development of high-drug-loading nanoparticles. ChemPlusChem. 2020;85(9):2143\u201357.","journal-title":"ChemPlusChem"},{"key":"3045_CR158","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","volume":"133","author":"A Gordillo-Galeano","year":"2018","unstructured":"Gordillo-Galeano A, Mora-Huertas CE. Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release. Eur J Pharm Biopharm. 2018;133:285\u2013308.","journal-title":"Eur J Pharm Biopharm"},{"issue":"5","key":"3045_CR159","doi-asserted-by":"publisher","first-page":"481","DOI":"10.4103\/0250-474X.58165","volume":"71","author":"S Lankalapalli","year":"2009","unstructured":"Lankalapalli S, Kolapalli VR. Polyelectrolyte complexes: a review of their applicability in drug delivery technology. Indian J Pharm Sci. 2009;71(5):481\u20137.","journal-title":"Indian J Pharm Sci"},{"key":"3045_CR160","unstructured":"Ankerfors C. Polyelectrolyte complexes: preparation, characterization, and use for control of wet and dry adhesion between surfaces. In: Chemical science and engineering. 2012, HTJ: Stockholm. p. 58."},{"issue":"4","key":"3045_CR161","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/1061186X.2020.1817042","volume":"29","author":"CY Wong","year":"2021","unstructured":"Wong CY, Al-Salami H, Dass CR. Fabrication techniques for the preparation of orally administered insulin nanoparticles. J Drug Target. 2021;29(4):365\u201386.","journal-title":"J Drug Target"},{"issue":"5","key":"3045_CR162","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.3390\/ijms24054289","volume":"24","author":"OR Guadarrama-Escobar","year":"2023","unstructured":"Guadarrama-Escobar OR, et al. Chitosan nanoparticles as oral drug carriers. Int J Mol Sci. 2023;24(5):4289.","journal-title":"Int J Mol Sci"},{"issue":"45","key":"3045_CR163","doi-asserted-by":"publisher","first-page":"19787","DOI":"10.1002\/anie.202008879","volume":"59","author":"Y Xiao","year":"2020","unstructured":"Xiao Y, et al. Oral insulin delivery platforms: strategies to address the biological barriers. Angew Chem Int Ed Engl. 2020;59(45):19787\u201395.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1\u20132","key":"3045_CR164","first-page":"18","volume":"46","author":"P Langguth","year":"1997","unstructured":"Langguth P, et al. The challenge of proteolytic enzymes in intestinal peptide delivery. J Control Release. 1997;46(1\u20132):18.","journal-title":"J Control Release"},{"issue":"3","key":"3045_CR165","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.jfda.2015.01.007","volume":"23","author":"MS Alai","year":"2015","unstructured":"Alai MS, Lin WJ, Pingale SS. Application of polymeric nanoparticles and micelles in insulin oral delivery. J Food Drug Anal. 2015;23(3):351\u20138.","journal-title":"J Food Drug Anal"},{"issue":"1","key":"3045_CR166","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1517\/17425247.2013.745509","volume":"10","author":"HJ Lemmer","year":"2013","unstructured":"Lemmer HJ, Hamman JH. Paracellular drug absorption enhancement through tight junction modulation. Expert Opin Drug Deliv. 2013;10(1):103\u201314.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"3045_CR167","doi-asserted-by":"publisher","first-page":"89","DOI":"10.4103\/0975-7406.76478","volume":"3","author":"R Shaikh","year":"2011","unstructured":"Shaikh R, et al. Mucoadhesive drug delivery systems. J Pharm Bioallied Sci. 2011;3(1):89\u2013100.","journal-title":"J Pharm Bioallied Sci"},{"issue":"5","key":"3045_CR168","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejps.2010.12.007","volume":"42","author":"A Makhlof","year":"2011","unstructured":"Makhlof A, Tozuka Y, Takeuchi H. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci. 2011;42(5):445\u201351.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"3045_CR169","first-page":"116","volume":"6","author":"W Dieterich","year":"2018","unstructured":"Dieterich W, Schink M, Zopf Y. Microbiota in the gastrointestinal tract. Med Sci (Basel). 2018;6(4):116.","journal-title":"Med Sci (Basel)"},{"issue":"9","key":"3045_CR170","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1039\/D0CS01127D","volume":"50","author":"M Sousa de Almeida","year":"2021","unstructured":"Sousa de Almeida M, et al. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine. Chem Soc Rev. 2021;50(9):5397\u2013434.","journal-title":"Chem Soc Rev"},{"key":"3045_CR171","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.117504","volume":"256","author":"AB Meneguin","year":"2021","unstructured":"Meneguin AB, et al. The role of polysaccharides from natural resources to design oral insulin micro- and nanoparticles intended for the treatment of diabetes mellitus: a review. Carbohydr Polym. 2021;256: 117504.","journal-title":"Carbohydr Polym"},{"issue":"7","key":"3045_CR172","doi-asserted-by":"publisher","first-page":"629","DOI":"10.2174\/1389201015666140915151319","volume":"15","author":"MA Lopes","year":"2014","unstructured":"Lopes MA, et al. Intestinal uptake of insulin nanoparticles: facts or myths? Curr Pharm Biotechnol. 2014;15(7):629\u201338.","journal-title":"Curr Pharm Biotechnol"},{"issue":"6","key":"3045_CR173","doi-asserted-by":"publisher","first-page":"887","DOI":"10.2174\/1567201820666230518161330","volume":"21","author":"A Barfar","year":"2024","unstructured":"Barfar A, et al. Oral insulin delivery: a review on recent advancements and novel strategies. Curr Drug Deliv. 2024;21(6):887\u2013900.","journal-title":"Curr Drug Deliv"},{"issue":"12","key":"3045_CR174","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1039\/D0BM00743A","volume":"8","author":"C Costa","year":"2020","unstructured":"Costa C, et al. All-in-one microfluidic assembly of insulin-loaded pH-responsive nano-in-microparticles for oral insulin delivery. Biomater Sci. 2020;8(12):3270\u20137.","journal-title":"Biomater Sci"},{"issue":"9","key":"3045_CR175","doi-asserted-by":"publisher","first-page":"5967","DOI":"10.1021\/acs.nanolett.9b01660","volume":"19","author":"PE Saw","year":"2019","unstructured":"Saw PE, et al. Stimuli-responsive polymer-prodrug hybrid nanoplatform for multistage siRNA delivery and combination cancer therapy. Nano Lett. 2019;19(9):5967\u201374.","journal-title":"Nano Lett"},{"key":"3045_CR176","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119827","volume":"237","author":"J Chen","year":"2020","unstructured":"Chen J, et al. Advances in nanomaterials for photodynamic therapy applications: status and challenges. Biomaterials. 2020;237: 119827.","journal-title":"Biomaterials"},{"issue":"1","key":"3045_CR177","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1186\/s12951-024-02614-1","volume":"22","author":"X Liu","year":"2024","unstructured":"Liu X, et al. Multifunctional nano-in-micro delivery systems for targeted therapy in fundus neovascularization diseases. J Nanobiotechnol. 2024;22(1):354.","journal-title":"J Nanobiotechnol"},{"issue":"3","key":"3045_CR178","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jconrel.2007.08.013","volume":"123","author":"M Bikram","year":"2007","unstructured":"Bikram M, et al. Temperature-sensitive hydrogels with SiO2-Au nanoshells for controlled drug delivery. J Control Release. 2007;123(3):219\u201327.","journal-title":"J Control Release"},{"issue":"11","key":"3045_CR179","first-page":"CD015385","volume":"11","author":"B Richter","year":"2023","unstructured":"Richter B, Bongaerts B, Metzendorf MI. Thermal stability and storage of human insulin. Cochrane Database Syst Rev. 2023;11(11):CD015385.","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"3045_CR180","doi-asserted-by":"publisher","first-page":"3001","DOI":"10.1529\/biophysj.107.107888","volume":"93","author":"PR Shorten","year":"2007","unstructured":"Shorten PR, McMahon CD, Soboleva TK. Insulin transport within skeletal muscle transverse tubule networks. Biophys J. 2007;93(9):3001\u20137.","journal-title":"Biophys J"},{"issue":"5","key":"3045_CR181","doi-asserted-by":"publisher","first-page":"3024","DOI":"10.1021\/acs.cgd.1c01463","volume":"22","author":"FJ Link","year":"2022","unstructured":"Link FJ, Heng JYY. Unraveling the impact of pH on the crystallization of pharmaceutical proteins: a case study of human insulin. Cryst Growth Des. 2022;22(5):3024\u201333.","journal-title":"Cryst Growth Des"},{"issue":"3\u20134","key":"3045_CR182","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1017\/S0033583508004721","volume":"41","author":"H Heerklotz","year":"2008","unstructured":"Heerklotz H. Interactions of surfactants with lipid membranes. Q Rev Biophys. 2008;41(3\u20134):205\u201364.","journal-title":"Q Rev Biophys"},{"issue":"5","key":"3045_CR183","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1177\/0268355514534648","volume":"30","author":"K Parsi","year":"2015","unstructured":"Parsi K. Interaction of detergent sclerosants with cell membranes. Phlebology. 2015;30(5):306\u201315.","journal-title":"Phlebology"},{"issue":"2","key":"3045_CR184","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/polym8020030","volume":"8","author":"J Venkatesan","year":"2016","unstructured":"Venkatesan J, et al. Seaweed polysaccharide-based nanoparticles: preparation and applications for drug delivery. Polymers (Basel). 2016;8(2):30.","journal-title":"Polymers (Basel)"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-03045-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-024-03045-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-024-03045-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T06:01:47Z","timestamp":1735452107000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-024-03045-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,29]]},"references-count":184,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3045"],"URL":"https:\/\/doi.org\/10.1186\/s12951-024-03045-8","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,29]]},"assertion":[{"value":"27 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"802"}}